Company page
Valneva Se
Valneva SE is a public company listed on the French market under the ticker VLA, with a market capitalization of approximately €497.39 million. The company focuses on developing and commercializing innovative vaccines for infectious diseases. Valneva aims to address unmet medical needs through its research and development efforts.
- Ticker
- VLA:EURONEXT
- Asset type
- Stock
- Market cap
- $497.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- EURONEXT
- Currency
- EUR